Wu, J., Zhang, J., Yin, Y., Shi, Y., Wu, X., Sun, T., Yang, C., Zhu, L., Li, Y., He, C. (2025). SIMRISE: A randomized phase III trial evaluating SIM0270 in combination with everolimus versus treatment of physician’s choice in patients with ER+/HER2- advanced breast cancer, previously treated with CDK4/6 inhibitors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps1128